Pathstone Holdings, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 2011612 ENGLEWOOD, NJ

Position in TEVA

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$4,939,769

+$2,804,819 QoQ

Shares Held

164,003

+139.7% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 87.25084297238466.ToString("F0")% Shared 0.3054822167887173.ToString("F0")% None 12.44367481082663.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $39,823,834 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	305,467	$7,309,824
2	ZTS	Zoetis Inc.	57,358	$6,780,288
3	TEVA	Teva Pharmaceutical Industries Ltd This page	164,003	$4,939,769
4	TAK	Takeda Pharmaceutical Co Ltd	241,293	$4,468,745
5	ALKS	Alkermes plc.	81,988	$2,899,094
6	UTHR	UNITED THERAPEUTICS Corp	4,828	$2,862,906
7	NBIX	Neurocrine Biosciences Inc	11,857	$1,562,041
8	HLN	Haleon plc	155,748	$1,559,036

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,939,769	164,003	+139.7%	Shares	Other	2026-05-11
2025-12-31	$2,134,950	68,406	+0.8%	Shares	Defined	2026-02-13
2025-09-30	$1,371,256	67,884	+1.2%	Shares	Other	2025-11-13
2025-06-30	$1,124,460	67,092	-4.6%	Shares	Sole	2025-08-12
2025-03-31	$1,080,448	70,296	-5.8%	Shares	Other	2025-05-15
2024-12-31	$1,645,351	74,653	+2.8%	Shares	Defined	2025-02-14
2024-09-30	$1,308,215	72,598	+6.5%	Shares	Sole	2024-11-07
2024-06-30	$1,107,372	68,146	+7.8%	Shares	Defined	2024-08-14
2024-03-31	$891,949	63,214	+43.9%	Shares	Sole	2024-05-13
2023-12-31	$458,617	43,929	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.